Clinical correlates of atypical femoral fracture
Authors:
- Joan C. LoJLJoan C. Lo
- Susie Y. HuangSHSusie Y. Huang
- Grace A. LeeGLGrace A. Lee
- Stutee KhandewalSKStutee Khandewal
- Jason ProvusJPJason Provus
- Bruce EttingerBEBruce Ettinger
- Joel R. GonzalezJGJoel R. Gonzalez
- Rita L. HuiRHRita L. Hui
- Christopher D. GrimsrudCGChristopher D. Grimsrud
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The impact of subtrochanteric fracture criteria on hip fracture classificationOsteoporosis International, 2011
- Bisphosphonate Use and Atypical Fractures of the Femoral ShaftNew England Journal of Medicine, 2011
- Cumulative Alendronate Dose and the Long-Term Absolute Risk of Subtrochanteric and Diaphyseal Femur Fractures: A Register-Based National Cohort AnalysisThe Journal of Clinical Endocrinology & Metabolism, 2010
- Atypical femoral stress fractures in bisphosphonate-free patientsOsteoporosis International, 2010
- Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral ResearchJournal of Bone and Mineral Research, 2010
- Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal FemurNew England Journal of Medicine, 2010
- Fragility fractures of the hip and femur: incidence and patient characteristicsOsteoporosis International, 2009
- Low-Energy Femoral Shaft Fractures Associated With Alendronate UseJournal of Orthopaedic Trauma, 2008
- An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?Injury, 2008
- Subtrochanteric insufficiency fractures in patients on alendronate therapyThe Journal of Bone and Joint Surgery. British volume, 2007